A Study to Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards.

Clinical trial NCT00730847 · TERMINATED

Trial details

NCT number: NCT00730847
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Human Papillomavirus Infection Leading to Cervical Cancer

Start date: 2008-09-17
Primary completion: 2012-01-16
Enrollment: 743

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.